Showing results (51-60 of 77) with videos related to
Sort By:
Pageof 8
Journal of Clinical Laboratory Analysis|August 26, 2003
Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR productsAgnes Juhasz, Paul Frankel, Catherine Cheng, et al.JCO Precision Oncology|September 28, 2023
Pan-Cancer Prevalence of Microsatellite Instability-High (MSI-H) Identified by Circulating Tumor DNA and Associated Real-World Clinical OutcomesPashtoon Murtaza Kasi, Leslie A Bucheit, Jiemin Liao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired hepatic function: a National Cancer Institute Organ Dysfunction Working Group studyTimothy W Synold, Chris H Takimoto, James H Doroshow, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10Charles A Butts, Keyue Ding, Lesley Seymour, et al.Cancer Chemotherapy and Pharmacology|June 9, 2004
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancerRobert J Morgan, Timothy W Synold, David Gandara, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2010
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshopRobert Pirker, Felix J F Herth, Keith M Kerr, et al.The New England Journal of Medicine|June 24, 2005
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancerTimothy Winton, Robert Livingston, David Johnson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2008
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancerGiorgio Vittorio Scagliotti, Purvish Parikh, Joachim von Pawel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2023
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung CancerGiorgio Vittorio Scagliotti, Purvish Parikh, Joachim von Pawel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung CancerSuresh Senan, Anthony Brade, Lu-Hua Wang, et al.Pageof 8